BNET Industries

Genentech Inc.

(DNA) is in the Pharma Industry

Last Fiscal Year Sales:$13.4B
  • Public
  • US
Dow Jones Description

Considered the founder of the biotechnology industry, Genentech has been delivering on the promise of biotechnology for more than 30 years, using human genetic information to discover, develop, manufacture and commercialize biotherapeutics that address significant unmet medical needs. Today, Genentech is among the world's leading biotech companies, with multiple products on the market for serious or life-threatening medical conditions, more than 100 projects in the pipeline and a long term plan for growth.

Chairman & Chief Executive OfficerArthur D. Levinson
Number of Employees 11,186
Contact Information

1 DNA Way

South San Francisco, California 94080-4990

www.gene.com

(650) 225-1000

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • Biogen Gains Edge in Drug Talks

    6/17/09 - Joint Venture / Alliance - View Story

  • Biogen says panel backs Genentech partnership

    6/16/09 - Merger / Acquisition - View Story

  • Biogen Idec, Inc. Massachusetts BIIB Announces Conclusion of Arbitration with Genentech, Inc. DNA

    6/17/09 - Joint Venture / Alliance - View Story

  • Arbitrator sides with Biogen in Rituxan dispute

    6/17/09 - Joint Venture / Alliance - View Story

  • Genentech licenses Bayhill drug for $25M cash, equity

    6/10/09 - Licensing / Contract - View Story

  • Emerging Drug Developer: Bayhill Therapeutics

    6/15/09 - Joint Venture / Alliance - View Story

  • Roche Downplays Avastin Failure, Defends Genentech Deal Value

    5/31/09 - Bond / Stock Rating - View Story

  • Tom Marsico Is Pound-the-Table Bullish

    5/28/09 - Merger / Acquisition - View Story

  • Drug firms eye deals to maintain growth

    5/10/09 - Merger / Acquisition - View Story

  • UC president recommends Desmond-Hellmann for UCSF chancellor

    5/01/09 - Joint Venture / Alliance - View Story

  • HIW, OSIP, SNY, WLT, FLEX and GMCR Expected To Be Higher After Earnings Releases on...

    4/29/09 - Joint Venture / Alliance - View Story

  • Genentech, Inc. (South San Francisco, CA)

    4/24/09 - Mgmt. Change Entering - Vice President - View Story

  • UPDATE 1-Seattle Genetics Q1 loss wider-than-expected

    4/23/09 - Joint Venture / Alliance - View Story

  • Analyst Available to Comment on Avastin's Failure in Clinical Trial for Early-Stage...

    4/23/09 - Merger / Acquisition - View Story

News & Analysis

genentech inc. - All News and Analysis

Those who viewed this also viewed...

Decision Makers

Name (plus bio) Position
Susan Desmond-Hellmann MD President, Product Development
David A. Ebersman Executive Vice President and Chief Financial Officer
Hal Barron MD Chief Medical Officer & Senior Vice President, Development
Stephen G. Juelsgaard Executive Vice President, Secretary and Chief Compliance Officer
Ian T. Clark Executive Vice President, Commercial
Patrick Y Yang PhD Executive Vice President, Product Operations
Richard H Scheller PhD Executive Vice President, Research
Marc Tessier-Lavigne Senior Vice President, Res Drug Discovery
Robert Garnick Senior Vice President, Regulatory, Quality & Compliance
Andrew C. Chan Vice President, Immunology Res
Ann L. Lee Vice President, Process Development
Anthony P. Hurley Vice President, Fill, Finish Manufacturing
Ashraf Hanna Vice President, Alliance Management & Pipeline Strategy Support
Charles Calderaro Vice President, Corp Engineering
Charles Johnson Vice President, Clinical Biotherapeutics
Claudia Estrin Vice President, Decision Support & Commercial Innovation
Corsee D. Sanders Vice President, Biometrics & Business Operations, Medical Affairs
David Broad Vice President & General Manager, Oceanside Product Operations
David Schenkein Vice President, Clinical Hematology & Oncology
Denise Smith-Hams Vice President, HR
Francis Jackson Vice President, Vacaville Prod Operations
Gary Harbour Vice President, Commercial Quality, South San Francisco
Genesio Murano Vice President, Regulatory Affairs
Gregory Baird Vice President, Corp Communications
Gwendolyn Fyfe Vice President, Clinical Hematology & Oncology
James P. Miller Vice President
Jennifer E. Cook Vice President, Marketing Development
John M Whiting Vice President Finance, Treasury and Procurement
John Orwin Vice President
John Pinion Vice President, External Quality
Joseph Barta Vice President, Compliance
Joseph S. McCracken Vice President, Business Development
Karen McCormick Vice President
Kenneth Hillan Vice President, Development Sciences
Kent Lieginger Vice President
Kevin McRaith Vice President
Leonard Kanavy Vice President, Commercial Operations
Markus Gemuend Vice President, Manufacturing Collaborations
Martin Babler Vice President
Michael D. Varney Vice President, Small Molecule Drug Discovery
Michael P. Miller Vice President, Sales & Marketing, HER Family
Pamela M. Klein Vice President, Clinical Oncology
Peter Carberry Vice President, Clinical Operations
Philippa Norman Vice President, Global Supply Chain
Quinton C. Oswald Vice President, Sales & Marketing
Richard B Brewer Vice President, Marketing
Ronald C. Branning Vice President, Quality, Global
Roy C. Hardiman Vice President
Scott Carmer Vice President, Sales & Marketing, Rituxan Immunology
Sean A. Johnston Vice President
Timothy L. Moore Vice President, Manufacturing, South San Francisco
Todd Pierce Vice President, Corp IT
Todd Rich Vice President, Clinical & Commercial Regulatory Affairs
Varun Nanda Vice President
Vince Anicetti Vice President, Prod Portfolio Management
Vishva Dixit Vice President, Molecular Oncology Res
W. Robert Arathoon Vice President, Corp Manufacturing Operations
Walter K. Moore Vice President, Govt Affairs
William N. Anderson Vice President, Sales & Marketing, Immunology
Herbert W. Boyer Co Founder
Richard Axel Co-founder
Avi Ashkenazi Director
Dan Eaton Director
Geoff Teeter Director, Corp Communications
Hamilton Mixon Director, Corp Security Services
Henry Lowman Director, Engineering
Kathee Littrell Director, Investor Relations
Lino Gonzalez Senior Director
Lisa Tuomi Associate Director, Investor Relations
Mark Sliwkowski Director
Mary Stutts Senior Director, Corp Communications
Mike Burchmore Director, Prod Management
Nicholas Bruggen Associate Director
Stuart Bunting Director
Wai Wong Director
Brad Failing Area Manager, Sales, Managed Care
D. Searle Manager, Marketing
Diane L. Parks Senior Vice President & General Manager, Specialty Therapeutics & Managed Care
Diane Schrick Prod Manager, Development
Sam Burst Division Manager, Sales
Robert Andreatta Controller
Amos Smith Consultant
Bradley Wolk Engr, Process Development
Chung Hsu Engr, Process Development
Colin Watanabe Programmer Analyst, Corp IT
Jonathan K.C. Knowles Head, Global Research
Robert van Reis Engr, Process Development
Charles A. Sanders Director
Grant Heidrich investor
Norman Fogelsong Venture Investor
Susan Desmond member

Board of Directors

Name (plus bio) Position
Arthur D. Levinson Chairman & Chief Executive Officer
Debra L. Reed Board of Directors
Erich Hunziker Board of Directors
William M. Burns Board of Directors

Arthur Levinson became chief executive officer of Genentech in July 1995. Levinson was appointed a member of the board of directors that same year and was named chairman of the board in 1999. Levinson joined the company in 1980 as a senior scientist, and he subsequently held the position of staff scientist and director of Cell Genetics at Genentech. He became vice president of Research Technology in 1989, vice president of Research in 1990, senior vice president of Research in 1992, and senior vice president of Research and Development in 1993. He has been a member of Genentech's executive committee since 1990. Prior to his employment with Genentech, Levinson was a postdoctoral fellow in the department of microbiology at the University of California, San Francisco. During his career, Levinson has served on the editorial boards of Molecular Biology and Medicine, Molecular and Cellular Biology, The Journal of Virology, and Virology. He also served on the boards of the Pharmaceutical Research and Manufacturers of America, the Biotechnology Industry Organization, and the California Healthcare Institute. Levinson has authored or co-authored more than 80 scientific articles and has been a named inventor on 11 United States patents, including inventions in the research of production of recombinant proteins. Levinson sits on the board of scientific consultants for the Memorial Sloan-Kettering Cancer Center and is a member of the advisory councils for the California Institute for Quantitative Biomedical Research (QB3), the Princeton University Department of Molecular Biology, and the Lewis-Sigler Institute for Integrative Genomics, also at Princeton. He also serves as a member of the executive council of the Technology Network. Levinson serves on the corporate boards of Apple Inc. and Google Inc. Levinson received the Irvington Institute's 1999 Corporate Leadership Award in Science and was honored the same year with the Corporate Leadership Award from the National Breast Cancer Coalition. He was inducted into the Biotech Hall of Fame at the 2003 Biotech Meeting of chief executive officers. BusinessWeek named Levinson one of the "Best Managers of the Year" in 2004 and 2005, and Institutional Investor named him "America's Best CEO" in the biotech category four years in a row (2004-2007). In 2006, Princeton University awarded Levinson the James Madison Medal for a distinguished career in scientific research and in biotechnology. Also in 2006, Barron's recognized Levinson as one of "The World's Most Respected CEOs," and the Best Practice Institute placed Levinson on their "25 Top CEOs" list. In 2008, Levinson was elected as a Fellow to the American Academy of Arts & Sciences. Levinson received his Bachelor of Science degree from the University of Washington, Seattle and earned a doctorate in biochemistry from Princeton University.

Organization Position Status
Genentech, Inc. Chairman & Chief Executive Officer Current
Princeton University Advisory Council, Lewis-Sigler Institute for Integrative Genomics Current
Princeton University Advisory Council, Department of Molecular Biology Current
QB3 Co Advisory Council Current
Memorial Sloan-Kettering Cancer Center Inc. Board of Scientific Consultants Current
Memorial Sloan-Kettering Cancer Center Inc. Member, Board of Scientific Consultants Current
Google Inc. Board of Directors Current
Apple Inc. Board of Directors Current
Genentech, Inc. Senior Vice President of R&D Former
University of California, San Francisco Postdoctoral Fellow Former
California Healthcare Institute, Inc. Board of Directors Former
Pharmaceutical Research and Manufacturers of America Board of Directors Former
Biotechnology Industry Organization Board of Directors Former
Princeton University Ph.D. in biochemistry Former
University of Washington Bachelor of Science degree in molecular biology Former
Organization Position Status
Genentech, Inc. President, Product Development Current
Organization Position Status
Genentech, Inc. Executive Vice President and Chief Financial Officer Current
Aquaya Executive Vice President and Chief Financial Officer Current
Intarcia Therapeutics, Inc. Director Current
Oppenheimer & Co. Inc. research analyst Former
Brown University Bachelor of Arts in Economics and International Relations Former
Genentech, Inc. member Former
Organization Position Status
Genentech, Inc. Chief Medical Officer & Senior Vice President, Development Current
Organization Position Status
Genentech, Inc. Executive Vice President, Secretary and Chief Compliance Officer Current
Wilson Sonsini Goodrich & Rosati associate Former
Iowa State University Master of Science degree Former
Organization Position Status
Genentech Foundation Executive Vice President, Commercial Operations Current
Genentech, Inc. Executive Vice President, Commercial Current
Vernalis plc Board of Directors Current
Genentech Foundation General Manager Former
Pharmacia Corporation Former
Southampton University Bachelor of Science Degree In Biological Sciences Former
Organization Position Status
Genentech, Inc. Executive Vice President, Product Operations Current
Merck & Co. Inc. Former
The Ohio State University doctorate in electrical engineering and computer science Former
University of Cincinnati Master of Science in electrical engineering Former
National Chiao Tung University Bachelor of Science Former
Organization Position Status
Genentech, Inc. Executive Vice President, Research Current
Genentech Foundation Executive Vice President, Research Current
National Academy of Sciences Board of Directors Current
The Academy of Arts & Sciences Board of Directors Current
The Academy of Arts & Sciences Member Current
National Academy of Sciences Member Current
Genentech Foundation Senior Vice President, Research Former
California Institute of Technology doctorate Former
University of Wisconsin Bachelor of Science Former
Organization Position Status
Genentech, Inc. Senior Vice President, Res Drug Discovery Current
Organization Position Status
Genentech, Inc. Senior Vice President, Regulatory, Quality & Compliance Current
Organization Position Status
Genentech, Inc. Vice President, Immunology Res Current
Organization Position Status
Genentech, Inc. Vice President, Process Development Current
Organization Position Status
Genentech, Inc. Vice President, Fill, Finish Manufacturing Current
Organization Position Status
Genentech, Inc. Vice President, Alliance Management & Pipeline Strategy Support Current
Organization Position Status
Genentech, Inc. Vice President, Corp Engineering Current
Organization Position Status
Genentech, Inc. Vice President, Clinical Biotherapeutics Current
Organization Position Status
Genentech, Inc. Vice President, Decision Support & Commercial Innovation Current
Organization Position Status
Genentech, Inc. Vice President, Biometrics & Business Operations, Medical Affairs Current
Organization Position Status
Genentech, Inc. Vice President & General Manager, Oceanside Product Operations Current
Organization Position Status
Genentech, Inc. Vice President, Clinical Hematology & Oncology Current
Organization Position Status
Genentech, Inc. Vice President, HR Current
Organization Position Status
Genentech, Inc. Vice President, Vacaville Prod Operations Current
Organization Position Status
Genentech, Inc. Vice President, Commercial Quality, South San Francisco Current
Organization Position Status
Genentech, Inc. Vice President, Regulatory Affairs Current
Organization Position Status
Genentech, Inc. Vice President, Corp Communications Current
Organization Position Status
Genentech, Inc. Vice President, Clinical Hematology & Oncology Current
Organization Position Status
Genentech, Inc. Vice President Current
Organization Position Status
Genentech, Inc. Vice President, Marketing Development Current
Organization Position Status
Genentech, Inc. Vice President Finance, Treasury and Procurement Current
Organization Position Status
Genentech, Inc. Vice President Current
Organization Position Status
Genentech, Inc. Vice President, External Quality Current
Organization Position Status
Genentech, Inc. Vice President, Compliance Current
Organization Position Status
Genentech, Inc. Vice President, Business Development Current
Organization Position Status
Genentech, Inc. Vice President Current
Organization Position Status
Genentech, Inc. Vice President, Development Sciences Current
Organization Position Status
Genentech, Inc. Vice President Current
Organization Position Status
Genentech, Inc. Vice President Current
Organization Position Status
Genentech, Inc. Vice President, Commercial Operations Current
Organization Position Status
Genentech, Inc. Vice President, Manufacturing Collaborations Current
Organization Position Status
Genentech, Inc. Vice President Current
Organization Position Status
Genentech, Inc. Vice President, Small Molecule Drug Discovery Current
Organization Position Status
Genentech, Inc. Vice President, Sales & Marketing, HER Family Current
Organization Position Status
Genentech, Inc. Vice President, Clinical Oncology Current
Organization Position Status
Genentech, Inc. Vice President, Clinical Operations Current
Organization Position Status
Genentech, Inc. Vice President, Global Supply Chain Current
Organization Position Status
Genentech, Inc. Vice President, Sales & Marketing Current
Organization Position Status
Agensys, Inc. President and CEO of Arca Discovery Current
ARCA Discovery, Inc. President and Chief Executive Officer Current
Genentech, Inc. Vice President, Marketing Current
Crest Asset Management, Inc. Partner Current
Dendreon Corporation Chairman Current
Corus Pharma, Inc. Board of Directors Current
ARCA Discovery, Inc. Board of Directors Current
Anesiva Inc. Board of Directors Current
Agensys, Inc. Board of Directors Current
SRI International Director Current
Scios Inc. Chief Executive Officer Former
Scios, Inc. CEO Former
Scios Inc. President Former
Scios, Inc. President Former
Heartport, Inc. Coo Former
Johnson & Johnson COO of Heartport Former
American Heart Association, Inc. chairman Former
Dendreon Corporation Board of Directors Former
Northwestern University M.B.A. Former
Virginia Polytechnic Institute and State University B.S. Former
Organization Position Status
Genentech, Inc. Vice President, Quality, Global Current
Organization Position Status
Genentech, Inc. Vice President Current
Organization Position Status
Genentech, Inc. Vice President, Sales & Marketing, Rituxan Immunology Current
Organization Position Status
Genentech, Inc. Vice President Current
Organization Position Status
Genentech, Inc. Vice President, Manufacturing, South San Francisco Current
Organization Position Status
Genentech, Inc. Vice President, Corp IT Current
Organization Position Status
Genentech, Inc. Vice President, Clinical & Commercial Regulatory Affairs Current
Organization Position Status
Genentech, Inc. Vice President Current
Organization Position Status
Genentech, Inc. Vice President, Prod Portfolio Management Current
Organization Position Status
Genentech, Inc. Vice President, Molecular Oncology Res Current
Organization Position Status
Genentech, Inc. Vice President, Corp Manufacturing Operations Current
Organization Position Status
Genentech, Inc. Vice President, Govt Affairs Current
Organization Position Status
Genentech, Inc. Vice President, Sales & Marketing, Immunology Current
Organization Position Status
Genentech, Inc. Co Founder Current
University of California, San Francisco Professor of Biochemistry Current
Genentech, Inc. Board of Directors Current
Allergan, Inc. Vice Chairman Current
National Academy of Sciences Board of Directors Current
Allergan, Inc. Board of Directors Former
National Academy of Sciences Member Former
Organization Position Status
Genentech, Inc. Co-founder Current
Columbia University University Professor, Investigator Former
University of California, San Francisco Former
Organization Position Status
Genentech, Inc. Director Current
Organization Position Status
Genentech, Inc. Director Current
Organization Position Status
Genentech, Inc. Director, Corp Communications Current
Organization Position Status
Genentech, Inc. Director, Corp Security Services Current
Organization Position Status
Genentech, Inc. Director, Engineering Current
The Johns Hopkins University Former
Organization Position Status
Genentech, Inc. Director, Investor Relations Current
Organization Position Status
Genentech, Inc. Senior Director Current
Organization Position Status
Genentech, Inc. Associate Director, Investor Relations Current
Organization Position Status
Genentech, Inc. Director Current
Organization Position Status
Genentech, Inc. Senior Director, Corp Communications Current
Organization Position Status
Genentech, Inc. Director, Prod Management Current
Organization Position Status
Genentech, Inc. Associate Director Current
Organization Position Status
Genentech, Inc. Director Current
Organization Position Status
Genentech, Inc. Director Current
Organization Position Status
Genentech, Inc. Area Manager, Sales, Managed Care Current
Organization Position Status
Genentech, Inc. Manager, Marketing Current
Organization Position Status
Genentech, Inc. Senior Vice President & General Manager, Specialty Therapeutics & Managed Care Current
Organization Position Status
Genentech, Inc. Prod Manager, Development Current
Organization Position Status
Genentech, Inc. Division Manager, Sales Current
Organization Position Status
Genentech, Inc. Controller Current
Organization Position Status
Columbia University Visiting Professor Current
Cambridge University Visiting Professor Current
Red Abbey, LLC Senior Advisor Current
Genentech, Inc. Consultant Current
Auckland University Visiting Professor Current
Incyte Corporation Consultant Current
University of Pennsylvania Professor Current
Merck & Co. Inc. Consultant Current
University of Pennsylvania Chairman Current
Kosan Biosciences, Inc. Board Advisor Current
Dihedron Corp Board Advisor Current
Pharmacopeia Drug Discovery Inc. Board Advisor Current
Provid Pharmaceuticals, Inc. Board of Directors Current
Monell Chemical Senses Center Member Current
The Rockefeller University Research Associate Former
The Rockefeller University Ph.D. Former
Bucknell University M.S. Degrees Former
Bucknell University B.S. Former
The Rockefeller University B.S. Former
Organization Position Status
Genentech, Inc. Engr, Process Development Current
Organization Position Status
Genentech, Inc. Engr, Process Development Current
Organization Position Status
Genentech, Inc. Programmer Analyst, Corp IT Current
Organization Position Status
Roche Holding Ltd. Managing Director, Global Pharmaceutical Research Current
Genentech, Inc. Head, Global Research Current
Genentech, Inc. Board of Directors Current
Chugai Pharmaceutical Co., Ltd. Board of Directors Current
University of East Anglia Honours Degree in Molecular Genetics Former
Organization Position Status
Genentech, Inc. Engr, Process Development Current
Organization Position Status
The University of North Carolina Trustee Current
marketRx Inc. Current
Feinstein Kean Healthcare Current
Vertex Pharmaceuticals Incorporated Chairman of the Board Current
Liposcience, Inc. Chairman of the Board Current
Venrock Associates Chairman of the Board of Directors Current
Icagen, Inc. Chairman Current
Project Hope Chairman Former
Pharmacopeia Drug Discovery Inc. Board of Directors Current
Radius Ventures, LLC Board of Directors Current
Genentech, Inc. Director Current
Csis Inc Board of Directors Current
Cephalon, Inc. Board of Directors Current
Trimeris, Inc. Director Current
Icagen, Inc. Board of Directors Current
Drug Safety Alliance, Inc. Board of Directors Current
Kendle International Inc. Director Current
Scios, Inc. Director Current
Reata Pharmaceuticals, Inc Board of Directors Current
Epiphany Biosciences, Inc. Board of Directors Current
Staffmark Board of Directors Current
Personalized Medicine Coalition Board of Directors Current
Science & Technology Group CEO Former
Massachusetts Gen Hospital General Director Former
Massachusetts General Hospital General Director Former
Harvard Medical School director of Massachusetts General Hospital Former
Harvard Medical School Professor of Medicine Former
Meredith College trustee Former
Scios Inc. Former
New York Academy of Sciences Chairman Former
The Commonwealth Fund Chairman Former
Genaera Corporation Board of Directors Former
Vertex Pharmaceuticals Incorporated Board of Directors Current
Squibb Corporation Board Member Former
Squibb Corporation Vice Chairman Former
Massachusetts General Hospital Director Former
Biopure Corporation Director Former
The University of Texas Southwestern Medical School M.D. Former
The University of Texas Former
Organization Position Status
Genentech, Inc. Board of Directors Current
Organization Position Status
Roche Holding Ltd. CFO Current
F. Hoffmann-La Roche Ltd. CFO Current
Chugai Pharmaceutical Co., Ltd. Board of Directors Current
Genentech, Inc. Board of Directors Current
Holcim Ltd. Board of Directors Current
Diethelm Keller Holding Ltd. Chief Executive Officer Former
Organization Position Status
Genentech, Inc. Board of Directors Current
Organization Position Status
Mayfield Fund Partner Emeritus Current
Prospect Venture Partners Advisor Current
DoveBid, Inc. Director Current
Cytokinetics, Inc. Board of Directors Current
Millennium Pharmaceuticals, Inc. Board of Directors Current
Genentech, Inc. investor Current
DoveBid, Inc. investor Current
SGI Inc. investor Current
Tularik, Inc. investor Current
Millennium Pharmaceuticals, Inc. investor Current
Amgen Inc. investor Current
Cytokinetics, Inc. investor Current
MIPS Technologies, Inc. investor Current
Immunex Corporation investor Current
Western Association of Venture Capitalists President Former
Aveo Pharmaceuticals, Inc. Former
Tularik, Inc. Chairman of the Board Former
Columbia University MBA Former
Stanford University BA Former
Organization Position Status
International Venture Partners, Inc. General Partner Current
Cortina Systems Corporation Board of Directors Current
Genentech, Inc. Venture Investor Current
Verisity, Ltd. Venture Investor Current
Aspect Software, Inc. Investor Current
3Com Corporation Venture Investor Current
Cypress Semiconductor Corporation Venture Investor Current
Silicon Graphics, Inc. Venture Investor Current
Artisan Components, Inc. Investor Current
WebEx Communications, Inc. Venture Investor Current
MIPS Technologies, Inc. Venture Investor Current
LSI Corporation Venture Investor Current
Applied Biosystems Group Venture Investor Current
Dust Networks Venture Investor Current
Linear Technology Corp. Venture Investor Current
SupportSoft, Inc. Venture Investor Current
Concur Technologies, Inc. Investor Current
Compaq Computers Investor Current
Websense Inc. Investor Current
Lam Research Corporation Investor Current
Polycom, Inc. Investor Current
Motion Computing, Inc. Investor Current
@Road, Inc. Venture Investor Current
Amgen Inc. Venture Investor Current
Quantum Corporation Venture Investor Current
Digital River, Inc. Venture Investor Current
Institutional Venture Partners General Partner Former
Hewlett-Packard Company computer programmer Former
McKinsey & Company, Inc. management consultant Former
Stanford University Board Member Former
Harvard Law School J.D Former
Harvard Business School M.B.A Former
Stanford University B.S. degree in Management Science & Engineering Former
Organization Position Status
Genentech, Inc. member Current
The University of California, San Francisco Assistant Professor Former
University of California, Berkeley Master of Science degree in Epidemiology and Biostatistics Former
University of Nevada Bachelor of Science in Pre-Medicine and her Medical Degree Former
University of California, San Francisco adjunct associate professor of Epidemiology and Biostatistics Former

Executive News

  • Someone at Apple Should Pay

    Motley Fool - 6/26/09 - View Story

  • Wanted: A Few Disruptive Leaders

    BusinessWeek - 6/25/09 - View Story

  • Experts: Apple Disclosure 'Falls Short'

    BusinessWeek - 6/23/09 - View Story

  • Apple adapts to Jobs' absence

    Akron Beacon Journal - 6/21/09 - View Story

  • Report: Apple's Steve Jobs had liver transplant while on leave

    Chicago Sun-Times - 6/20/09 - View Story

  • Google Maintains Cool Facade as Antitrust Heat Builds

    E-Commerce Times - 6/11/09 - View Story

  • Google downplays antitrust concerns

    Silicon Valley/San Jose Business Journal - 6/11/09 - View Story

  • U.S. Steps Up Probe of Google Book Deal

    The Wall Street Journal Interactive Edition - 6/11/09 - View Story

  • DOJ Probes Hiring at Tech Firms

    The Wall Street Journal Interactive Edition - 6/05/09 - View Story

  • Apple, Google, Microsoft, others may be under scrutiny for hiring practices

    New Mexico Business Weekly - 6/03/09 - View Story

  • Reports: U.S. probes Silicon Valley tech giants' hiring

    Silicon Valley/San Jose Business Journal - 6/03/09 - View Story

  • Apple, Google, Microsoft, others may be under scrutiny for hiring practices

    Los Angeles Business from bizjournals - 6/03/09 - View Story

  • Report: Antitrust probe of Apple, Google, Yahoo

    San Francisco Business Times - 6/03/09 - View Story

  • New Warning on Hormone Replacement

    New York Times - 5/31/09 - View Story

  • Phase III Study Showed Patients Lived Longer Without Advanced Lung Cancer Progressing When Tarceva Was Added to Avastin as First-Line Maintenance Therapy

    Reuters - 5/30/09 - View Story

  • Phase III Study Showed Patients Lived Longer Without Advanced Lung Cancer Progressing When Tarceva Was Added to Avastin as First-Line Maintenance Therapy

    Business Wire - 5/30/09 - View Story

  • Genentech Announces Full Results from First Phase III Study of Avastin in Early-Stage Colon Cancer

    Business Wire - 5/30/09 - View Story

  • Avastin Plus Commonly Used Chemotherapies Improved Progression-Free Survival inAdvanced Breast Cancer

    Reuters - 5/29/09 - View Story

  • Avastin Plus Commonly Used Chemotherapies Improved Progression-Free Survival in Advanced Breast Cancer

    Business Wire - 5/29/09 - View Story

  • Genentech, Biogen Idec seek new FDA approval for Rituxan

    Triangle Business Journal - 5/20/09 - View Story

advertisement
IndustryTop Rated

Brought to you by CBS MoneyWatch.com

advertisement